公开(公告)号：US11440954B2

公开(公告)日：2022-09-13

申请号：US16863971

申请日：2020-04-30

Applicant: Prometheus Biosciences, Inc. ,  Cedars-Sinai Medical Center

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  J. Monty Watkins ,  Patricia McNeeley ,  Janine Bilsborough ,  Bradley Henkle ,  Stephan R. Targan

IPC: C07K16/24 ,  C07K16/28 ,  C12N5/10 ,  C12N15/09 ,  C12N15/63 ,  A61P1/04 ,  A61P1/00 ,  A61K9/00 ,  C07K14/525 ,  C07K14/715 ,  A61K39/395 ,  A61K39/00

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US20230192835A1

公开(公告)日：2023-06-22

申请号：US17931049

申请日：2022-09-09

Applicant: Prometheus Biosciences, Inc. ,  CEDARS-SINAI MEDICAL CENTER

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  J. Monty Watkins ,  Patricia McNeeley ,  Janine Bilsborough ,  Bradley Henkle ,  Stephan R. Targan

IPC: C07K16/24 ,  A61P1/04 ,  C07K16/28 ,  A61P1/00 ,  A61K9/00 ,  C12N15/09 ,  C12N15/63 ,  C12N5/10

CPC classification number: C07K16/24 ,  A61P1/04 ,  C07K16/241 ,  C07K16/28 ,  A61P1/00 ,  A61K9/0019 ,  C07K16/2875 ,  C12N15/09 ,  C12N15/63 ,  C12N5/10 ,  A61K39/3955

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US20200255510A1

公开(公告)日：2020-08-13

申请号：US16863971

申请日：2020-04-30

Applicant: Prometheus Biosciences, Inc.

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  J. Monty Watkins

IPC: C07K16/24 ,  A61P1/04 ,  C07K16/28

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US10689439B2

公开(公告)日：2020-06-23

申请号：US16694814

申请日：2019-11-25

Applicant: Prometheus Biosciences, Inc.

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  J. Monty Watkins

IPC: C07K16/24 ,  C07K16/28 ,  A61K39/395 ,  A61P1/04 ,  C07K14/525 ,  C07K14/715 ,  A61K39/00

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

公开(公告)号：US20200157203A1

公开(公告)日：2020-05-21

申请号：US16694814

申请日：2019-11-25

Applicant: Prometheus Biosciences, Inc.

Inventor： Jeffry D. Watkins ,  Cindy T. Dickerson ,  J. Monty Watkins

IPC: C07K16/24 ,  A61P1/04

Abstract: Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).